Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart
AUTOR(ES)
Ding, Jian-Hua
FONTE
Nature Publishing Group
RESUMO
Many genetic diseases are caused by mutations in cis-acting splicing signals, but few are triggered by defective trans-acting splicing factors. Here we report that tissue-specific ablation of the splicing factor SC35 in the heart causes dilated cardiomyopathy (DCM). Although SC35 was deleted early in cardiogenesis by using the MLC-2v-Cre transgenic mouse, heart development appeared largely unaffected, with the DCM phenotype developing 3–5 weeks after birth and the mutant animals having a normal life span. This nonlethal phenotype allowed the identification of downregulated genes by microarray, one of which was the cardiac-specific ryanodine receptor 2. We showed that downregulation of this critical Ca2+ release channel preceded disease symptoms and that the mutant cardiomyocytes exhibited frequency-dependent excitation–contraction coupling defects. The implication of SC35 in heart disease agrees with a recently documented link of SC35 expression to heart failure and interference of splicing regulation during infection by myocarditis-causing viruses. These studies raise a new paradigm for the etiology of certain human heart diseases of genetic or environmental origin that may be triggered by dysfunction in RNA processing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=380988Documentos Relacionados
- Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
- Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy
- Tissue-specific spatial organization of genomes
- Tissue-specific expression of the rat galanin gene.
- Tissue-specific silencing of a transgene in rice